Skip to main content

Want a detailed portfolio tracker?

Skye Bioscience (SKYE) P/E (2018 - 2026)

Skye Bioscience (SKYE) P/E from Apr 2, 2018 to Jul 21, 2026. The TTM Skye Bioscience (SKYE) P/E is -0.36. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Skye Bioscience (SKYE)

YearP/EChange
2026-0.36-14.53%
2025-0.42-86.48%
2024-3.13+689.74%
2023-0.40-39.76%
2022-0.66-74.59%
2021-2.59+100.34%
2020-1.29-98.12%
2019-68.95+2386.39%
2018-2.77N/A

Comparison Skye Bioscience (SKYE) P/E with competitors

Skye Bioscience (SKYE) P/E is -0.36.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.47%
NBYStablecoin Development Corp0.00-101.19%
ENLVEnlivex Ltd0.07-120.67%
FGENFibroGen Inc0.24-166.34%
CHRSCoherus Biosciences Inc0.85-334.50%
FBIOFortress Biotech Inc0.95-362.28%
ORMPOramed Pharmaceuticals Inc1.50-515.39%
AGENAgenus Inc3.01-931.75%
INVAInnoviva Inc3.15-971.66%
VXRTVaxart Inc3.55-1081.02%
CRMDCorMedix Inc3.63-1102.77%
CVACCureVac N.V.4.45-1328.62%
GLPGGalapagos NV4.86-1442.82%
SRPTSarepta Therapeutics Inc4.88-1449.23%
ABEOAbeona Therapeutics Inc5.39-1588.91%
ABUSArbutus Biopharma Corp5.60-1646.43%
ZVRAZevra Therapeutics Inc5.89-1727.02%
SPROSpero Therapeutics Inc6.23-1821.32%
CGENCompugen Ltd6.31-1844.95%
RIGLRigel Pharmaceuticals6.87-1999.19%
SLXNSilexion Therapeutics Corp7.30-2116.37%
OMEROmeros Corporation9.26-2658.79%
AUPHAurinia Pharmaceuticals Inc9.58-2748.94%
PLXProtalix BioTherapeutics Inc10.89-3109.88%
ACADAcadia Pharmaceuticals Inc11.73-3341.35%
TBPHTheravance Biopharma Inc12.26-3488.82%
ADMAAdma Biologics Inc12.42-3531.94%
HRMYHarmony Biosciences Holdings Inc13.82-3919.41%
SABSSAB Biotherapeutics Inc14.14-4006.75%
NAGENiagen Bioscience Inc14.82-4195.21%
INCYIncyte Corp15.82-4472.80%
REGNRegeneron Pharmaceuticals Inc15.86-4482.22%
PBYIPuma Biotechnology Inc17.32-4885.45%
CPRXCatalyst Pharmaceuticals Inc17.44-4919.61%
EXELExelixis Inc17.54-4946.89%
TGTXTG Therapeutics Inc18.97-5341.55%
MDXGMimedx Group Inc20.55-5779.99%
XOMAXOMA Royalty Corp22.87-6421.93%
ARGXArgen X SE24.30-6815.29%
CTMXCytomX Therapeutics Inc24.82-6959.86%
XOMAOXOMA Royalty Corp25.34-7104.60%
HALOHalozyme Therapeutics Inc25.62-7181.68%
XOMAPXOMA Royalty Corp25.67-7194.51%
VRTXVertex Pharmaceuticals Inc27.99-7836.97%
RPRXRoyalty Pharma plc - Class A28.69-8028.44%
SLNOSoleno Therapeutics Inc29.02-8119.03%
ASNDAscendis Pharma A/S30.09-8414.81%
LGNDLigand Pharmaceuticals Inc - Class B37.91-10577.83%
APLSApellis Pharmaceuticals Inc39.02-10884.38%
BMRNBiomarin Pharmaceutical Inc42.21-11766.18%
KRYSKrystal Biotech Inc45.34-12631.68%
ONCBeiGene Ltd69.54-19319.06%
PHARPharming Group N.V.75.03-20835.00%
TECHBio-Techne Corp101.96-28278.48%
VCELVericel Corp109.92-30479.22%
ALNYAlnylam Pharmaceuticals Inc117.96-32702.30%
GMABGenmab140.29-38872.50%
TLXTelix Pharmaceuticals Ltd162.15-44914.57%
CORTCorcept Therapeutics Inc212.86-58927.95%